135. Aicardi syndrome
[
1 clinical trial,
9 drugs（DrugBank:
3 drugs),
0 target gene / 0 target pathway ]
Searched query = "Aicardi syndrome"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2014-002710-23-FR | 29 January 2018 | N/A | N/A - AGS | MedDRA version: 18.0 Level: PT Classification code 10054935 Term: Aicardi's syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] | Trade Name: Zidovudine Product Name: Zidovudine Product Code: J05A F01 Pharmaceutical Form: Oral solution INN or Proposed INN: Zidovudine Other descriptive name: retrovir Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Trade Name: lamivudine Product Name: lamivudine Product Code: GX CJ7 Pharmaceutical Form: Oral solution INN or Proposed INN: lamivudine Other descriptive name: epivir Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Trade Name: Abacavir Product Name: Abacavir Product Code: GX 623 Pharmaceutical Form: Oral drops, solution INN or Proposed INN: abacavir Other descriptive name: ziagen Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 20- | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | Not Recruiting | Female: yes Male: yes | 24 | Phase 2 | France |